US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Savannah Goldfields Ltd (SVGO) 銘柄情報

Savannah Goldfields Ltd (SVGO)

0.001

0.00

(0.00%)

終了 6月11日 3:00PM

Savannah Goldfields Ltd (SVGO) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.001

( - )

買値

0.001

売値

0.001

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.001

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 4,708,918

発行済株式数

2,241,577,039

配当利回り

PER

-0.9

1 株当たり利益 (EPS)

-0.01

歳入

2.35M

純利益

-11.7M

Savannah Goldfields Limited engages in the exploration, evaluation, and development of gold and silver properties in Australia. It holds 100% interest in the Agate Creek gold project covering an area of approximately 1,539 square kilometers located in north Queensland; and Georgetown project located... Savannah Goldfields Limited engages in the exploration, evaluation, and development of gold and silver properties in Australia. It holds 100% interest in the Agate Creek gold project covering an area of approximately 1,539 square kilometers located in north Queensland; and Georgetown project located in Queensland. The company was formerly known as Laneway Resources Limited and changed its name to Savannah Goldfields Limited in October 2022. Savannah Goldfields Limited was incorporated in 1986 and is based in Brisbane, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

www.savannahgoldfields.com

本社

Brisbane, Australia

設立

1986

Savannah Goldfields Ltd is listed in the Materials sector of the オーストラリア証券取引所 with ticker SVGO. The last closing price for Savannah Goldfields was AUD0. Over the last year, Savannah Goldfields shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Savannah Goldfields currently has 2,241,577,039 shares in issue. The market capitalisation of Savannah Goldfields is AUD2.24 million. Savannah Goldfields has a price to earnings ratio (PE ratio) of -0.90.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SVGO - Frequently Asked Questions (FAQ)

What is the current Savannah Goldfields Ltd share price?

The current share price of Savannah Goldfields Ltd is AUD 0.001

How many Savannah Goldfields Ltd shares are in issue?

Savannah Goldfields Ltd has 2,241,577,039 shares in issue

What is the market cap of Savannah Goldfields Ltd?

The market capitalisation of Savannah Goldfields Ltd is AUD 2.24M

What is the 1 year trading range for Savannah Goldfields Ltd share price?

Savannah Goldfields Ltd has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Savannah Goldfields Ltd?

The price to earnings ratio of Savannah Goldfields Ltd is -0.9

What is the cash to sales ratio of Savannah Goldfields Ltd?

The cash to sales ratio of Savannah Goldfields Ltd is 8.6

What is the registered address of Savannah Goldfields Ltd?

The registered address for Savannah Goldfields Ltd is Matisse Towers, Brisbane, Queensland, 4000

What is the Savannah Goldfields Ltd website address?

The website address for Savannah Goldfields Ltd is www.savannahgoldfields.com

Which industry sector does Savannah Goldfields Ltd operate in?

Savannah Goldfields Ltd operates in the Mining sector

haha11

$SPY...15.....NOW STILL UNDER MA50 Monitor %B....

S..725.48...

https://stockcharts.com/sc3/ui/?s=SPY&id=p54653479432&a=234724271

ysung

So when do they come back from vacation ???

jrf30

very complete report. I like that. Don]t think the volatility would put this at 0.31, but all the rest looks good, and there is a lot of information on that page. Thank you.

JCESOSA

JCESOSA 3分前

Agreed. Something bigger must be on the way

EpicSage

EpicSage 3分前

$OTLC ’s PDAOAI™ indexes 28M PubMed abstracts on Qdrant & introduces manifold folding to fix the infinity problem in biomedical retrieval — a milestone for AI-driven drug discovery.

Full story: https://wix.to/siP3GXN

#Oncotelic #PDAOAI #Biotech #AI

sjoseph

sjoseph 4分前

He doesn’t have 400 million after 1/10 Reverse split. Around 41 million and that will never hit the market now. GL

88TH MAN

88TH MAN 4分前

USMJ: Bullish!!!

jay14

Perhaps noise makers, drenching up old news from 1993 or even 2003 should contact Susan Bala directly....
Ask her to join TMMI legal team with all this information....
Speculation of what's coming up with this new court case, with a new judge is just that speculation, and nothing more!

Truenorth2016

Truenorth2016 4分前

I dont think the tweet is saying they will never provide the detailed amounts of the contract, they are just saying they cant release the info now....they will do like they did the other contract and eventually provide the info in a Tweet

iHub News

iHub News 5分前

K-Tech Solutions Advances 5 MW Computing Infrastructure Project in Canada With Construction and Testing Underway (KMRK)June 11, 2026 10:39 AM
IH Market News

FrostyIsland3

FrostyIsland3 5分前

LC2020: There is only question investors need NWBO to answer now. Has NWBO received a CHM Letter regarding the DCVax-L MAA?

If the answer is yes, NWBO is going through an appeal of the CHM Letter now and the MHRA will probably reject the DCVax-L MAA.

If the answer is

iHub News

iHub News 5分前

Laser Photonics Completes Laser Shield Anti-Drone Prototype, Advancing LSAD Demonstration Phase (LASE)June 11, 2026 10:35 AM
IH Market News

iHub News

iHub News 5分前

Purple Biotech Presents New IM1240 Preclinical Data Showing Anti-Tumor Activity and Broad Therapeutic Window (PPBT)June 11, 2026 10:38 AM
IH Market News

nowwhat2

nowwhat2 5分前

Absolutely !.....Makes sense !

Meanwhile ;

https://investorshub.advfn.com/uimage/uploads/2026/6/11/hzpvfgutsi_drunk_today_yet.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/11/d[fzkgutsi_girl_swag.jpg

https://investorshub.advfn.co

LOB

Saw Large Bid at .0097 for 3 Mins, then it disappeared without being Hit .. ?? .01+ today or tomorrow??

iHub News

iHub News 5分前

Enliven Therapeutics Reports Positive Phase 1 CML Data and FDA Alignment for Phase 3 Trial (ELVN)June 11, 2026 10:36 AM
IH Market News

iHub News

iHub News 5分前

Super Micro Prices $7 Billion AI Server Financing Package to Support $39 Billion Order Backlog (SMCI)June 11, 2026 10:37 AM
IH Market News

Karma84

Karma84 6分前

Well the idiot has only admitted in 18 posts here to buying with insider and cohen telling him when to buy. So do the math. Cohen couldn’t and he’s facing up to life in prison now.

https://x.com/opinioncasino/status/2064356081531269126?s=46&t=GJF4mYq9oxQgaoD9fp1cvw

tisdal

I think today is what we'll see from here on out. Rising on low volume. Not many sellers out there.

IMHO, the MMs are looking for inventory. They are going to drop it to kick off sell orders. They will run it up to kick off sell orders.

In the end, I think the dem

joe botts

joe botts 6分前

jrf30

I put in for 1,000 shares of the IPO. Don't know if I'll get ANY or not. Doubt I get more than 100 IF they give me any. Will find out after the market close today. KNock on wood! I doubt I buy on the open market tomorrow. Just hoping to get some at the $135 level. :-)

zdog1954

zdog1954 7分前

Thanks for posting, now that the dam has been breached, maybe the licenses from all these others will start streaming in.

vlispxpert

vlispxpert 7分前

TM does have history of upper $160's bounce level...so it may flush $170 breakdown, but loading here is almost fish in barrel imo

MrBean-4

MrBean-4 7分前

rumor at SWA is that the company has long term plans to acquire a couple of 787's to fly out of Austin and one other airport for European destinations

BBANBOB

BBANBOB 8分前

Augster
I would suggest that since ISOPET is already in use their goal was only to have a RADIO ACTIVE PRODUCTION license so they could then inhouse manufacture and legally handle/possess the RADIO ACTIVE MATERIAL

Savannah Goldfields

Hsbc Bank Usa Na Capped ...

Solarvest BioEnergy

Molecular Future

iNAV db xtrackers S&P 50...

Virios Therapeutics

Deutsche Bank Luxembourg

4.8% until 18apr26 4.8% ...

Exchange Traded

Lifeist Wellness

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。